EMV 0.00% $1.92 emvision medical devices ltd

Ann: Trial Progressing on Target and ASA Milestone Achieved, page-18

  1. 13,440 Posts.
    lightbulb Created with Sketch. 2632
    Are you not across the very encouraging results of the pilot trial conducted in 2020?

    These results have provided the platform for 2 further years of hardware and software enhancements by EMV's in-house team and the UQ. The enhanced device is now the subject of the 12-month pivotal trials at 3 leading stroke hospitals.

    Its now a matter of watch this space
 
watchlist Created with Sketch. Add EMV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.